Tags: cancermetforminmyeloid leukemiaburn scarsmarjolin's ulcer
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Advances in Cancer Therapies and Diagnostics - about 2 months ago Tapping Into Immunotherapy’s Potential to Help More People - 12 months ago | |
| 2 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | Why bone marrow transplants are becoming less common - 2 months ago | |
| 3 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 4 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 5 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | The latest updates on cancer research from the weekend - 11 months ago | |
| 6 | Alex Wilkins New Scientist Reporter New Scientist. London, England | Radioactive ion beam could target tumours more precisely - 5 months ago | |
| 7 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 8 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | STAT+: A new drug offers a rare option for brain cancer treatment — and inspires hopes for more - 5 months ago STAT+: With an old approach but new energy, ADCs take center stage as promising cancer treatments - over 1 year ago STAT+: Results on Novartis prostate cancer therapy could expand its use - over 1 year ago | |
| 9 | James Woodford New Scientist Ocean Correspondent. South Coast, New South Wales | ||
| 10 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer - about 1 year ago Futile Immunotherapy for Cancer Grows More Common - about 1 year ago |